Most patients with early stage testicular cancer can be cured, and patients with late stage can also get relatively good therapeutic effect, and the five-year survival rate of early stage patients can reach more than 95%, while that of late stage is about 30%. Clinical testicular cancer mainly refers to primary testicular cancer, which is further divided into two categories: seminomas and non-seminomas, among which seminomas account for the majority. Most of the early testicular cancers can be treated by radical surgery, and spermatogonial cell tumor is more sensitive to radiotherapy. After the comprehensive treatment strategy of radical surgery and postoperative adjuvant radiotherapy, most of the testicular cancer patients with early pathological type of spermatogonial cell tumor can generally be cured, and the level of five-year survival rate of the patients can be as high as more than 95%. Patients who are not feeling well need to consult the doctor for examination and early treatment.